Both biliverdin and bilirubin have anti-obesity and anti-glycaemic effects40, while increased Hmox-1 levels ameliorate fatty liver development through recruitment of FGF2141. Here, HMOX1 is linked to obesity due to melanocortin 4 receptor deficiency.